2003, Richard received the Thomson Medal from the International Mass Spectrometry Society "for outstanding achievements in mass spectrometry and for distinguished service to international mass spectrometry." He received the Field and Franklin Award from the American Chemical Society in 2006, the Eastern Analytical Society 2010 Award for Achievements in Mass Spectrometry, and the HUPO Distinguished Achievement Award in Proteomic Sciences in 2010.
Over his career, Richard has made multiple seminal contributions to the field of molecular analysis by MS. These innovations form the foundation for technologies that are employed worldwide today and have been key to the widespread application of MS to biological and clinical research. Developments from Richard's laboratory have led to significant advances in our ability to analyze complex biological mixtures and provided the innovative basis for on-line capabilities of MS. Richard engineered the development of systems such as continuousflow fast atom bombardment mass spectrometry [1] and micro (nano)-electrospray mass spectrometry [2] . These developments successfully coupled 'soft-ionization' with separation techniques such as liquid chromatography and capillary electrophoresis, making it possible to analyze complex biological mixtures. His patented micro-electrospray technology is now used worldwide for most MS-based proteomics platforms [3] , enabling techniques such as multi-dimensional liquid chromatography mass spectrometry (LC-MS) and also tandem LC-MS/MS for the identification of proteins. Several important application areas resulted from this technology, including ultra-high sensitivity methods for analysis of neuropeptides [2] , and molecular analysis in living animals through combination of microdialysis and high sensitivity mass spectrometry [4] [5] [6] . He was among the first to demonstrate and use enzymes effectively with MS, including kinetic analysis of enzyme activity [7] , and an early demonstration of a technique that today is referred to as ladder sequencing. These contributions further solidified MS as a technology of critical importance in providing an understanding of the role of proteins and other biological molecules in health and disease.
Over the past 10 years, Richard has directed his focus toward the development and application of Imaging Mass Spectrometry in basic science and clinical translational studies. He pioneered the spatial analysis (imaging) of tissues to generate specific molecular weight-based maps by mass spectrometry; he is now applying Imaging MS to biological research and to difficult clinical problems for vastly improved diagnoses and prognoses of human disease and to assess and direct patient care. In his work at Vanderbilt University, he employed matrixassisted laser desorption/ionization mass spectrometry (MALDI MS) for the direct spatial molecular analysis of tissues that has led to a quantum jump in the ability to produce discrete molecular images of cells and tissues [8] [9] [10] [11] . His work has applied Imaging MS to studies of complex biological systems as well as diseases such as diabetic nephropathy, melanoma, breast and prostate cancer, macular degeneration, as well as others, for the study of protein and lipid expression in situ with molecular localizations in tissue and cells. This usage has greatly advanced the role of 'omics' approaches in translational research whereby the molecular signature of a tissue, whether solid tissue or biological fluid, can be used for both diagnostic and prognostic evaluation of patients and also to assess treatment and response. The technology now has significant applications in molecular pathology, opening a new paradigm for the assessment of diagnostic and prognostic outcomes from the direct phenotypic expression of biomolecules in patient biopsies [12] .
Richard's work in the area of Imaging MS alone has resulted in about 150 research articles from his lab on the development or application of this technology that have been cited over 8500 times. More impressive is the impact of his work; since publication of the seminal paper in 1997 [8] , approximately 2500 papers have been published on the subject of MALDI IMS, and these articles have been cited more than 33,000 times. Further evidence of the growth of the technology are the numerous commercial platforms that have been developed and the number of sessions dedicated to Imaging MS at many national and international meetings.
This Special Focus of JASMS highlights work devoted to the advancement of Imaging Mass Spectrometry. This issue begins with an insightful "Perspective" by the awardee, in which Richard reflects on the rapid development of the field, and its incredible potential for unparalleled advances in science and medicine. Fifteen contributions from colleagues and friends then describe the richness and breadth of the field, including innovative developments in methodologies, software, and hardware, as well as wide-ranging applications in neurobiology, forensics, and toxicology, among many others: 
